April 2, 2015
FDA White Oak Campus
Silver Spring, MD
Event Website: Click here
On April 2, 2015, FDA is conducting a public meeting on Breast Cancer Patient-Focused Drug Development. FDA is interested in obtaining patient input on the impact of breast cancer on daily life and patients’ views on currently available therapies to treat the condition.
This website will be updated as meeting materials are developed.